BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34504305)

  • 1. Bone morphogenetic protein induces bone invasion of melanoma by epithelial-mesenchymal transition via the Smad1/5 signaling pathway.
    Gao J; Muroya R; Huang F; Nagata K; Shin M; Nagano R; Tajiri Y; Fujii S; Yamaza T; Aoki K; Tamura Y; Inoue M; Chishaki S; Kukita T; Okabe K; Matsuda M; Mori Y; Kiyoshima T; Jimi E
    Lab Invest; 2021 Nov; 101(11):1475-1483. PubMed ID: 34504305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p130Cas induces bone invasion by oral squamous cell carcinoma by regulating tumor epithelial-mesenchymal transition and cell proliferation.
    Yaginuma T; Gao J; Nagata K; Muroya R; Fei H; Nagano H; Chishaki S; Matsubara T; Kokabu S; Matsuo K; Kiyoshima T; Yoshioka I; Jimi E
    Carcinogenesis; 2020 Aug; 41(8):1038-1048. PubMed ID: 31996896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
    Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
    Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway.
    Zhao Q; Dong D; Chu H; Man L; Huang X; Yin L; Zhao D; Mu L; Gao C; Che J; Liu Q
    Cell Cycle; 2021 Jun; 20(12):1147-1162. PubMed ID: 34110955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic protein-4-induced epithelial-mesenchymal transition and invasiveness through Smad1-mediated signal pathway in squamous cell carcinoma of the head and neck.
    Xu T; Yu CY; Sun JJ; Liu Y; Wang XW; Pi LM; Tian YQ; Zhang X
    Arch Med Res; 2011 Feb; 42(2):128-37. PubMed ID: 21565626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2.
    Gordon KJ; Kirkbride KC; How T; Blobe GC
    Carcinogenesis; 2009 Feb; 30(2):238-48. PubMed ID: 19056927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic proteins enhance an epithelial-mesenchymal transition in normal airway epithelial cells during restitution of a disrupted epithelium.
    McCormack N; Molloy EL; O'Dea S
    Respir Res; 2013 Mar; 14(1):36. PubMed ID: 23509993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP4 Regulates EMT to be Involved in non-Syndromic Cleft lip With or Without Palate.
    Hong JW; Yu Y; Wang LS; Li Z; Zhang R; Wang Q; Ding Z; Zhang JP; Zhang MR; Xu LC
    Cleft Palate Craniofac J; 2023 Nov; 60(11):1462-1473. PubMed ID: 35702016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLI2-mediated melanoma invasion and metastasis.
    Alexaki VI; Javelaud D; Van Kempen LC; Mohammad KS; Dennler S; Luciani F; Hoek KS; Juàrez P; Goydos JS; Fournier PJ; Sibon C; Bertolotto C; Verrecchia F; Saule S; Delmas V; Ballotti R; Larue L; Saiag P; Guise TA; Mauviel A
    J Natl Cancer Inst; 2010 Aug; 102(15):1148-59. PubMed ID: 20660365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo.
    Buijs JT; Rentsch CA; van der Horst G; van Overveld PG; Wetterwald A; Schwaninger R; Henriquez NV; Ten Dijke P; Borovecki F; Markwalder R; Thalmann GN; Papapoulos SE; Pelger RC; Vukicevic S; Cecchini MG; Löwik CW; van der Pluijm G
    Am J Pathol; 2007 Sep; 171(3):1047-57. PubMed ID: 17724140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritis.
    Verschueren PC; Lories RJ; Daans M; Théate I; Durez P; Westhovens R; Luyten FP
    Ann Rheum Dis; 2009 Jan; 68(1):117-23. PubMed ID: 18276742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
    Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA
    Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition.
    Qiao B; Johnson NW; Chen X; Li R; Tao Q; Gao J
    Oncol Rep; 2011 Aug; 26(2):455-61. PubMed ID: 21567100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial-mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway.
    Liu D; Liu J; Li Y; Liu H; Hassan HM; He W; Li M; Zhou Y; Fu X; Zhan J; Wang Z; Yang S; Chen P; Xu D; Wang X; DiSanto ME; Zeng G; Zhang X
    Prostate; 2021 Dec; 81(16):1435-1449. PubMed ID: 34553788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemigliptin Inhibits Interleukin-1β-Induced Endothelial-Mesenchymal Transition via Canonical-Bone Morphogenetic Protein Pathway.
    Hong OK; Lee SS; Yoo SJ; Lee MK; Kim MK; Baek KH; Song KH; Kwon HS
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):384-395. PubMed ID: 32615723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.
    Sinnberg T; Levesque MP; Krochmann J; Cheng PF; Ikenberg K; Meraz-Torres F; Niessner H; Garbe C; Busch C
    Mol Cancer; 2018 Feb; 17(1):59. PubMed ID: 29454361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
    Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T
    Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of bone morphogenetic protein binding sites and Smad1/5 activation in human vascular cells.
    Upton PD; Long L; Trembath RC; Morrell NW
    Mol Pharmacol; 2008 Feb; 73(2):539-52. PubMed ID: 17989347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis.
    Na YR; Seok SH; Kim DJ; Han JH; Kim TH; Jung H; Lee BH; Park JH
    Cancer Sci; 2009 Nov; 100(11):2218-25. PubMed ID: 19735263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.